Texolite Block Filler

Product Description

Texolite Block Filler was a specialty masonry coating product manufactured by United States Gypsum Company (USG) during the period from approximately 1958 to 1966. As its name suggests, the product was formulated to fill and level the coarse, porous surface of concrete masonry units — commonly known as cinder blocks or concrete blocks — before finish coatings or paints were applied. This type of block filler was a practical solution in industrial and commercial construction, where concrete masonry walls required a smooth, consolidated surface to accept paint or other protective finishes.

United States Gypsum was one of the dominant building materials manufacturers in the United States throughout the twentieth century, producing a wide range of wallboard, plaster, joint compound, and specialty coating products. Texolite Block Filler represented one of USG’s industrial-grade offerings, distinct from consumer-facing joint compounds but sharing certain formulation characteristics common to the era — including, according to litigation records, the inclusion of asbestos as a functional additive.

The product’s intended use was primarily on the interior and exterior walls of industrial facilities, warehouses, commercial buildings, and similar structures where concrete masonry construction was standard. Application was typically by brush, roller, or spray equipment, depending on the scale of the project and the surface conditions of the block.

Asbestos Content

Litigation records document that Texolite Block Filler contained chrysotile asbestos as a constituent ingredient during its years of production. Chrysotile, also known as white asbestos, is a serpentine mineral fiber that was widely incorporated into construction products throughout the mid-twentieth century. In products like block fillers and heavy-bodied coatings, chrysotile fibers served several functional purposes: they improved tensile strength and resistance to cracking, helped bind the material during drying and cure, and contributed to the product’s ability to bridge the gaps and voids in coarse masonry surfaces.

The use of chrysotile in building materials of this type was standard practice among major manufacturers during the 1958–1966 production window. Regulatory frameworks requiring disclosure of asbestos content or warnings to end users had not yet been established at the federal level. The Occupational Safety and Health Administration (OSHA) would not issue its first asbestos standard until 1971, and the comprehensive regulations governing asbestos-containing materials in buildings — including the Asbestos Hazard Emergency Response Act (AHERA) of 1986 — were decades away from enactment.

Plaintiffs in litigation have alleged that United States Gypsum knew or had reason to know, during the years Texolite Block Filler was produced, that asbestos fibers posed serious health risks to workers who handled or applied the product, and that the company failed to provide adequate warnings to protect those workers.

How Workers Were Exposed

The primary population at risk from Texolite Block Filler was industrial workers involved in the application, mixing, and surface preparation tasks associated with the product. Because Texolite was designed for industrial and commercial construction rather than residential use, exposure was concentrated among workers in trades and settings where large-scale masonry finishing was performed.

Exposure to asbestos fibers from Texolite Block Filler could occur at several stages of product handling. Workers who opened bags of dry block filler and mixed the product with water — or who handled pre-mixed formulations — could disturb asbestos-containing dust during the preparation process. Applying the material by brush or roller to rough concrete block surfaces also had the potential to generate airborne particles, particularly if the product was applied vigorously or if excess material was scraped, smoothed, or worked into the surface texture of the block.

Once applied, Texolite Block Filler was subject to sanding or grinding in some applications to achieve the level surface required before finish painting. Dry sanding of hardened asbestos-containing coatings is among the higher-exposure activities documented in occupational health literature, as the mechanical abrasion releases previously bound fibers into the breathing zone. Workers performing this type of surface preparation in enclosed or poorly ventilated spaces faced particularly significant exposure potential.

Litigation records document that industrial workers employed in construction, building maintenance, and facilities work during the late 1950s and 1960s used products including Texolite Block Filler without the benefit of respiratory protection, engineering controls, or warnings about the hazards of asbestos inhalation. Bystander exposure was also possible, as workers in the same facility performing unrelated tasks could inhale fibers that became airborne during mixing or application activities nearby.

The latency period for asbestos-related diseases — typically ranging from ten to fifty years between initial exposure and clinical diagnosis — means that workers exposed to Texolite Block Filler during its production years could be experiencing health consequences today. Diseases associated with occupational asbestos exposure include mesothelioma, asbestosis, lung cancer, and other pulmonary conditions recognized under OSHA and AHERA regulatory frameworks.

There is no active asbestos bankruptcy trust associated specifically with United States Gypsum’s Texolite Block Filler product line. USG did not reorganize under Chapter 11 bankruptcy proceedings in connection with asbestos liabilities in the same manner as certain other major building products manufacturers who established dedicated compensation trusts. As a result, legal claims arising from Texolite Block Filler exposure are pursued through the civil court system rather than through a trust fund claims process.

Plaintiffs have alleged in litigation that United States Gypsum is liable for injuries sustained by workers exposed to asbestos-containing products including Texolite Block Filler under theories including negligence, strict product liability, and failure to warn. Litigation records document that claimants have sought compensation for medical expenses, lost wages, pain and suffering, and related damages arising from asbestos-related disease diagnoses.

Individuals who believe they were exposed to Texolite Block Filler during its production years between 1958 and 1966, and who have subsequently been diagnosed with mesothelioma, lung cancer, asbestosis, or another asbestos-related condition, may have legal options available to them. The strength and viability of any individual claim depends on the ability to document product identification, establish the timeline and nature of exposure, and connect that exposure to a diagnosed illness.

Because of the complexity of asbestos litigation and the importance of documenting product identification accurately, individuals with potential claims are encouraged to consult with an attorney who has experience handling asbestos-related cases. Legal time limits — known as statutes of limitations — apply to asbestos claims and vary by state; prompt consultation with qualified legal counsel is important to preserving available legal rights.